These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 870773)

  • 41. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
    Swartz SL; Williams GH; Hollenberg NK; Dluhy RG; Moore TJ
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1071-4. PubMed ID: 6989849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension.
    Williams GH; Braley LM; Menachery A
    J Clin Invest; 1982 Jan; 69(1):31-7. PubMed ID: 6274915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered sodium perception in essential hypertensive patients following rapid volume expansion.
    Conlin P; Moore T; Williams G; Hollenberg N
    J Hum Hypertens; 1999 Oct; 13(10):701-6. PubMed ID: 10516741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension.
    Beretta-Piccoli C; Weidmann P; Boehringer K; Link L; Bianchetti MG; Morton JJ
    J Clin Endocrinol Metab; 1984 Aug; 59(2):316-20. PubMed ID: 6736206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
    Williams GH; Hollenberg NK; Brown C; Mersey JH
    J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine inhibits the aldosterone response to upright posture.
    Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
    Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
    Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional derangements in the regulation of aldosterone secretion in hypertension.
    Williams GH; Hollenberg NK
    Hypertension; 1991 Nov; 18(5 Suppl):III143-9. PubMed ID: 1937678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
    Braley LM; Menachery A; Rystedt L; Williams GH
    Endocrinology; 1989 Sep; 125(3):1310-4. PubMed ID: 2547581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responsiveness of plasma aldosterone to angiotensin II in patients with diabetes mellitus.
    Morimoto S; Uchida K; Kigoshi T; Hosojima H; Yamamoto I; Azukizawa S
    Endocrinol Jpn; 1983 Oct; 30(5):671-8. PubMed ID: 6368211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Fisher ND; Hurwitz S; Ferri C; Jeunemaitre X; Hollenberg NK; Williams GH
    Hypertension; 1999 Sep; 34(3):388-94. PubMed ID: 10489382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arterial and venous angiotensin II in normal subjects. Relation to plasma renin activity and plasma aldosterone concentration, and response to posture and volume changes.
    Walker WG; Moore MA; Horvath JS; Whelton PK
    Circ Res; 1976 Jun; 38(6):477-83. PubMed ID: 773568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in adrenal responsiveness and potassium balance with shifts in sodium intake.
    Adler GK; Moore TJ; Hollenberg NK; Williams GH
    Endocr Res; 1987; 13(4):419-45. PubMed ID: 3329091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
    Taylor T; Moore TJ; Hollenberg NK; Williams GH
    Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
    Tuck ML; Dluhy RG; Williams GH
    J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renin suppression by saline is blunted in nonmodulating essential hypertension.
    Rabinowe SL; Redgrave JE; Shoback DM; Podolsky S; Hollenberg NK; Williams GH
    Hypertension; 1987 Oct; 10(4):404-8. PubMed ID: 3308701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.